Creative inventions and ideas that show next-level thinking. Terror charge filed in Jan. 6 case I asked 3 restaurant pros to name the most annoying thing diners do ...

Serhii Tyschenko, a Ukrainian combat medic, spent 472 days in a bunker. His case appears to be an extreme example of a problem that has long plagued Kyiv’s military. By Cassandra Vinograd and ...

A large Chinese research team has developed an air quality model called EPICC (Emission and atmospheric Processes Integrated and Coupled Community Model) that demonstrates improved accuracy in its ...

TransDigm Group is a core capital gain investment, driven by exceptional management, unique business model, and dominant market positioning. TDG’s value creation model leverages proprietary, ...

A new Swiss airline pitching itself as a go-to carrier for crisis response offers an intriguing twist: it plans to be a non-profit. Geneva-based Bluelight aims to kick off operations next year using a ...

Since its launch in 2012 and its acquisition by AceVector Group (Snapdeal) in 2015, the company has grown at a steady pace and remained profitable In FY25, its standalone revenue from operations grew ...

A few days ago, Google finally explained why its best AI image generation model is called Nano Banana, confirming speculation that the moniker was just a placeholder that stuck after the model went ...

The big picture: OpenAI has completed a sweeping overhaul of its ownership and governance structure, ending months of negotiations with Microsoft and securing a path to operate as a for-profit public ...

OpenAI on Tuesday said it had completed its recapitalization, splitting the AI lab into a for-profit corporation nested inside a non-profit foundation. It’s the end result of a complex legal process ...

Tesla is recalling approximately 13,000 recent Model 3 and Model Y vehicles built earlier this year due to a battery pack defect that can result in power loss. In August, Tesla started getting reports ...

ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the second agreement with a major pharmaceutical company, AstraZeneca, to bring American drug prices in line with the ...